TSE:4530Pharmaceuticals
Hisamitsu Pharmaceutical (TSE:4530) Margin Improvement Challenges Cautious Narrative After 34% Earnings Jump
Hisamitsu Pharmaceutical (TSE:4530) delivered a notable earnings performance, with net income rising 34.3% over the past year and five-year average earnings growth running at 14% annually. Net profit margins improved to 12.7% from 9.8%, and while revenue is forecast to grow 4.6% per year, future earnings growth is expected to be modest at just 0.3% annually. The company's current share price of ¥4,104 is below one discounted cash flow estimate of fair value at ¥9,258.81, which adds to a...